quadraScope Venture Fund
Venture capitalActively deployingBoston · 2 people tracked
Find your way into quadraScope Venture Fund
338 people in our graph share verified history with the quadraScope Venture Fund team — schools, employers, funds. One of them is your warm intro.
Investment thesis
quadraScope focuses on the emerging rejuvenation and longevity biotech market, investing in companies addressing the biological hallmarks of aging—including genomic instability, telomere attrition, epigenetic alterations, cellular senescence, and mitochondrial dysfunction. The firm invests across the drug development lifecycle, from preclinical research to clinical development stages, backing diverse therapeutic modalities including nanomedicines, cellular reprogramming, regenerative medicine, and lipid-based metabolic treatments that target the root biological causes of aging-related diseases.
Source: firm website, verified Aug 11, 2026.
Team · 2 people
from public directories
What they invest in
from 10 of 13 portfolio companiesBiotech ×8Longevity ×6Healthtech ×5Digital Health ×4AI & Machine Learning ×3Deep Tech ×2Medical Devices ×2Wellness & Fitness ×1
HQs:United States×6
Investments · 13 tracked
founders shown can be your intro pathBy year:2026 · 12019 · 12 dated
HealthtechMiami, US
Agustin Fernandez Santana III(Executive Officer, Director)Jeffrey B. Madden(Executive Officer, Director)inDavid Buchsbaum(Executive Officer)Frank Mattner(Director)
BoardWalter Schmidt(Director)
Alden Scientific is a biotech company with over 40 scientists, bioinformaticians, engineers, clinicians, and researchers developing immunological research capabilities.
AI & Machine LearningBiotechDigital HealthCambridge, US
James Heywood(CEO & Founder)
Co-investorsiSelect FundService Provider CapitalDeep Future
BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development.
AI & Machine LearningBiotechDeep TechLongevity
Dr. Peterson
Co-investorsBioGenerator VenturesMissouri Technology Corporation
Cosmica builds OrganAge™, a blood-based biomarker tool that scores biological aging across nine physiological systems, and an intervention engine that ranks foods, supplements, and activities by how they act on a person's aging-related genes.
BiotechDigital HealthLongevity
David Furman(Founder & Chief Executive Officer)Abhay Saini(Co-founder & Chief Operating Officer)inFei Wu(Chief Scientific Officer)
Deciduous Therapeutics develops small molecule and immunomodulatory therapies targeting senescent cells to treat age-related diseases including Type 1 diabetes, autoimmunity, and metabolic disorders.
BiotechDigital HealthLongevitySan Francisco, US
Robin Mansukhani(CEO and Co-Founder)inAnil Bhushan(Scientific Founder)in
BoardDylan Morris(Director)in
Co-investorsage1Bold Capital PartnersCornucopian Capital ManagementCRV (Charles River Ventures)Owl CapitalAxial VC+1 more
A clinic offering personalized longevity medicine programs designed to extend healthspan through scientifically-proven interventions, combining advanced diagnostics and therapies sourced from cutting-edge research.
Digital HealthHealthtechLongevityWellness & FitnessMiami, US
Petr Sramek(Co-founder & Managing Partner)
Immunis Biomedical develops multi-active biologics based on stem cell-derived secretomes — cell-free therapeutics containing proteins, lipids and growth factors — aimed at treating age-related and immune-related diseases.
BiotechHealthtechLongevityIrvine, US
Gabriel Nistor(Executive Officer)
BoardTakahide Koda(Director)Daniel Kraft(Director)Hans Keirstead(Chairman of the Board)
Co-investorsBold Capital PartnersJLSRemiges Ventures, Inc.
Co-investorsLauder PartnersMelnichek Investments
Repair Biotechnologies develops the Cholesterol Degrading Platform, a therapeutic approach for treating conditions caused by localized accumulations of excess cholesterol.
BiotechHealthtechMedical DevicesSyracuse, US
Guilherme Cherman Perdigao de Oliveira(Executive Officer, Director)Reason("CEO's full legal name is ""Reason""")Anthony Matthew Chow(Director)
BoardKelsey Moody(Director)
Co-investorsThynk Capital
Vincere Biosciences develops small-molecule therapeutics targeting mitochondrial quality control and mitophagy, primarily for neurodegenerative diseases including Parkinson's disease.
AI & Machine LearningBiotechDeep TechLongevity
Co-investorsBeiersdorf Innovation FundBeresford VenturesDraper AssociatesPortal Innovations
Portfolio news
latest coverage across their companiesImmunis Biomedical · revenanas.com · Jun 19, 2026
Alden Scientific · oncimmune.com · Jul 23, 2025
Frequently asked questions
- How many investments has quadraScope Venture Fund made?
- quadraScope Venture Fund has 13 tracked investments, including 1 dated in the last 24 months.
- What sectors does quadraScope Venture Fund focus on?
- quadraScope Venture Fund focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is quadraScope Venture Fund located?
- quadraScope Venture Fund is headquartered in Boston, US.
- Who does quadraScope Venture Fund co-invest with?
- quadraScope Venture Fund most often shares deals with Bold Capital Partners, BioGenerator Ventures, CRV (Charles River Ventures), among 18 tracked co-investors.
Media · Podcasts & interviews
from their channelLongevity Nation 2025
quadraScope Ventures
Mitochondrial dysfunction
quadraScope Ventures
Chronic inflammation
quadraScope Ventures
BioChange – transforming tissue regeneration
quadraScope Ventures
Maintaining mitochondrial health – interview with Dr. Behrouz, co-founder & CEO @ Vincere Bio
quadraScope Ventures
Key trends in longevity science and market – 2024 Longevity Nation Conference
quadraScope Ventures
Images
Co-investors · 2
Cyberstarts is a venture firm focused on cybersecurity startups, backing founders who have overcome significant challenges and using a systematic process to identify urgent problems in the sector.
Canada's leading digital health venture capital firm investing in early-stage and high-growth technology companies transforming healthcare delivery across North America. The firm provides capital alongside hands-on operational guidance, commercial introductions, and go-to-market strategy support.
Firms observed investing alongside quadraScope Venture Fund, from public investor directories. Shared companies are the overlap with quadraScope Venture Fund's recorded portfolio.
Similar investors
Future Positive Capital is a European deep-tech fund that ties its entire thesis to the Future Cones foresight framework, explicitly focusing on preferable futures and positioning itself as a futures-thinking, systems-change VC rather than a generic climate or impact fund. The firm hard-wires impact into its economics by contractually indexing more than 100% of partners' carried interest to portfolio companies achieving both financial and measurable impact outcomes, while specializing in capital-intensive, highly technical step-change solutions for planetary-scale problems like robotics for wind farm operations, large-scale carbon removal, and ecosystem restoration.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
EQT Life Sciences, formerly LSP (Life Sciences Partners), is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech.
5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.